Novavax, Inc (NASDAQ:NVAX) currently has a daily average trading volume of 8.32M but it saw 5518086 shares traded in last market. With a market cap of 1.13B USD, the company’s current market price of $6.99 came falling about -2.24 while comparing to the previous closing price of $7.15. In past 52 weeks, the stock remained buoying in the range of price level as high as $23.86 and as low as $5.01.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BTIG Research which initiated the stock as “Buy” in its note to investors issued on February 28, 2025, recommending a price target of $19 for it. JP Morgan downgraded its recommendation for the stock as a “Underweight” from “Neutral” on July 30, 2024 while assigning a price target of $8.
Over the week, NVAX’s stock price is moving -2.78% down while it is 15.16% when we observe its performance for the past one month. Year-to-date it is -13.06% down and over the past year, the stock is showing a downside performance of -61.64%.
Currently, Novavax, Inc’s total number of outstanding shares is 161.96M with 8.74% of that held by the insiders while 57.28% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 324.46%. It has a price to earnings ratio (P/E ratio) of 2.64 while having a 19.62 of forward P/E ratio. Stock’s beta reads 2.77. Stock has a price to sale or P/S ratio amounts to 0.90. Its return on asset (ROA) is 36.18% on average.
